Cite
HARVARD Citation
Hinchcliff, E. et al. (2019). Poly-ADP-ribose polymerase inhibitor use in ovarian cancer: expanding indications and novel combination strategies. International journal of gynecological cancer. 29 (5), pp. 956-968. [Online].